Placebo, nocebo, and lessebo effects are very frequent in patients with both neurological and psychiatric disorders. Interestingly, the neural mechanisms underlying placebo effects have been found to be the same as or similar to mechanisms targeted by active pharmaceutical interventions for many of these disorders. In the case of functional neurological disorders (FNDs), there are shared neural substrates between the central nervous system “placebo network” and the dysfunctional networks implicated in the pathophysiology. These networks are primarily involved in emotion regulation, stress responses, and the sense of self-agency. Therefore, placebo effects have also been discussed as therapeutic interventions in FNDs. Such an approach, however, has a variety of ethical implications evolving around informed consent, autonomy, nonmaleficence, beneficence, and justice. In this paper, we discuss the use of placebo, nocebo, and lessebo in FNDs as well as related ethical issues. Overall, the use of placebo in FNDs is currently still considered controversial both for diagnostic as well as therapeutic purposes. Although it is a safe and almost unique intervention, its use violates the core principles of medical ethics and doctor–patient interactions involving autonomy or openness in the therapeutic relationship.
Introduction: Both people with schizophrenia (SCZ) and Tourette syndrome (TS) have been found to be commonly stigmatized, but stereotypes held for both have never been directly compared. Clinicians and students of healthcare professions have been shown to also be affected by stereotypical beliefs. Media portrayals frequently perpetuate stereotypes, while accurate depictions could raise awareness and reduce stigma. Methods: The aim of this study was to compare stereotypes regarding SCZ and TS and their associations with social media consumption. We conducted an online survey amongst psychology students in the UK ( N = 69, age M = 20.48 ± 1.75, range 18–26 years, 57 females). Results: Overall, both diagnoses were seen neutrally. Participants felt neutral about or disagreed with most stereotypes. However, SCZ was perceived as significantly unpredictable. In comparison to SCZ, people with TS were seen as less dangerous, violent, disruptive and unpredictable. Correlations did not show significant associations between daily hours spent on social media, seen portrayals, the belief that the media influences subjective beliefs, and negative attitudes towards TS/SCZ. Discussion: Our results suggest neutral to positive attitudes towards SCZ and TS in current psychology students. Compared to TS, SCZ is more affected by stereotypes. Given the small, local (UK) sample in this study, future studies should include more large-scale global samples to elicit a potential shift in attitudes towards mental health conditions in young healthcare professionals and its relation to the media.